President and CEO Huang Jen Hsun sold $26,383,025 worth of shares (240,000 units at $109.93), decreasing direct ownership by 0.31% to 77,574,995 units (SEC Form 4)

$NVDA
Semiconductors
Technology
Get the next $NVDA alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HUANG JEN HSUN

(Last) (First) (Middle)
C/O NVIDIA CORPORATION
2788 SAN TOMAS EXPRESSWAY

(Street)
SANTA CLARA CA 95051

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NVIDIA CORP [ NVDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/29/2024 S(1) 23,369 D $111.8076(2) 77,791,626 D
Common Stock 07/29/2024 S(1) 34,315 D $112.3601(3) 77,757,311 D
Common Stock 07/29/2024 S(1) 22,487 D $113.3188(4) 77,734,824 D
Common Stock 07/29/2024 S(1) 20,817 D $114.6734(5) 77,714,007 D
Common Stock 07/29/2024 S(1) 17,842 D $115.4828(6) 77,696,165 D
Common Stock 07/29/2024 S(1) 1,170 D $116.1079(7) 77,694,995 D
Common Stock 07/30/2024 S(1) 1,000 D $102.854(8) 77,693,995 D
Common Stock 07/30/2024 S(1) 8,794 D $103.6757(9) 77,685,201 D
Common Stock 07/30/2024 S(1) 32,562 D $104.5481(10) 77,652,639 D
Common Stock 07/30/2024 S(1) 24,594 D $105.4372(11) 77,628,045 D
Common Stock 07/30/2024 S(1) 8,540 D $106.5551(12) 77,619,505 D
Common Stock 07/30/2024 S(1) 10,485 D $107.4363(13) 77,609,020 D
Common Stock 07/30/2024 S(1) 14,960 D $108.5924(14) 77,594,060 D
Common Stock 07/30/2024 S(1) 5,995 D $109.2693(15) 77,588,065 D
Common Stock 07/30/2024 S(1) 1,523 D $110.4946(16) 77,586,542 D
Common Stock 07/30/2024 S(1) 11,547 D $111.4202(17) 77,574,995 D
Common Stock 604,387,280 I By Trust(18)
Common Stock 49,489,560 I By Partnership(19)
Common Stock 22,280,000 I By Irrevocable Trust(20)
Common Stock 50,078,000 I By Irrevocable Remainder Trust(21)
Common Stock 29,684,280 I The Lori Lynn Huang 2016 Annuity Trust II Agreement
Common Stock 29,684,280 I The Jen-Hsun Huang 2016 Annuity Trust II Agreement
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024.
2. Represents weighted average sales price. The shares were sold at prices ranging from $111.36 to $111.99. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
3. Represents weighted average sales price. The shares were sold at prices ranging from $112.00 to $112.99. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
4. Represents weighted average sales price. The shares were sold at prices ranging from $113.00 to $113.94. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
5. Represents weighted average sales price. The shares were sold at prices ranging from $114.03 to $114.99. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
6. Represents weighted average sales price. The shares were sold at prices ranging from $115.00 to $115.98. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
7. Represents weighted average sales price. The shares were sold at prices ranging from $116.00 to $116.27. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
8. Represents weighted average sales price. The shares were sold at prices ranging from $102.66 to $102.99. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
9. Represents weighted average sales price. The shares were sold at prices ranging from $103.01 to $103.99. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
10. Represents weighted average sales price. The shares were sold at prices ranging from $104.01 to $104.99. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
11. Represents weighted average sales price. The shares were sold at prices ranging from $105.00 to $105.99. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
12. Represents weighted average sales price. The shares were sold at prices ranging from $106.00 to $106.99. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
13. Represents weighted average sales price. The shares were sold at prices ranging from $107.00 to $107.98. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
14. Represents weighted average sales price. The shares were sold at prices ranging from $108.04 to $108.99. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
15. Represents weighted average sales price. The shares were sold at prices ranging from $109.01 to $109.72. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
16. Represents weighted average sales price. The shares were sold at prices ranging from $110.05 to $110.95. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
17. Represents weighted average sales price. The shares were sold at prices ranging from $111.02 to $111.93. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
18. The shares are held by Jen-Hsun Huang and Lori Huang, as co-trustees of the Jen-Hsun & Lori Huang Living Trust, u/a/d May 1, 1995 (the "Trust"), of which the Reporting Person is a trustee.
19. The shares are held by J. and L. Huang Investments, L.P., of which the Trust is the general partner.
20. The shares are held by The Huang 2012 Irrevocable Trust, of which the Reporting Person is a trustee.
21. The shares are held by The Huang Irrevocable Remainder Trust u/a/d February 19, 2016, of which the Reporting Person is a trustee.
Remarks:
/s/ Rebecca Peters, Attorney-in-Fact for Jen-Hsun Huang 07/31/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $NVDA alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NVDA

DatePrice TargetRatingAnalyst
11/21/2024$145.00 → $160.00Overweight
Barclays
11/21/2024$155.00 → $170.00Overweight
Analyst
11/21/2024$150.00 → $165.00Buy
Goldman
11/21/2024$165.00 → $185.00Overweight
Wells Fargo
11/21/2024$167.00 → $169.00Buy
Truist
11/21/2024$150.00 → $190.00Outperform
Robert W. Baird
11/21/2024$170.00 → $190.00Buy
The Benchmark Company
11/21/2024$189.00 → $190.00Outperform
Evercore ISI
More analyst ratings

$NVDA
Press Releases

Fastest customizable press release news feed in the world

See more
  • NVDX Is The Best Performing ETF of 2024!

    The first 2x NVDA ETF in USA (Ticker: NVDX) led the ETF market with a 383% total return REX Financial ("REX"), a leader in innovative exchange-traded products, is proud to highlight that the T-Rex 2X Long NVIDIA Daily Target ETF (NVDX) was the best performing exchange-traded fund (ETF) of 2024, achieving a total return exceeding 383% in 2024, outperforming the second best performing ETF by over 38%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250115412925/en/(Graphic: Business Wire) Launched on October 19, 2023, NVDX was the first ever 2X daily target NVIDIA ETF available in the U.S. and has quickly gained traction among in

    $NVDA
    Semiconductors
    Technology
  • NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare

    SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- J.P. Morgan Healthcare Conference -- NVIDIA today announced new partnerships to transform the $10 trillion healthcare and life sciences industry by accelerating drug discovery, enhancing genomic research and pioneering advanced healthcare services with agentic and generative AI. The convergence of AI, accelerated computing and biological data is turning healthcare into the largest technology industry. Healthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc Institute, are using the latest NVIDIA technologies to develop solutions that will help advance human health. These solutions include AI agents that can speed clinical trials

    $NVDA
    Semiconductors
    Technology
  • NVIDIA Announces Blueprint for AI Retail Shopping Assistants

    NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- NRF—NVIDIA today announced the NVIDIA AI Blueprint for retail shopping assistants, a generative AI reference workflow designed to transform shopping experiences online and in stores. The blueprint — built on the NVIDIA AI Enterprise and NVIDIA Omniverse™ platforms — helps developers create AI-powered digital assistants that work alongside and support human workers. These digital assistants can deliver the expertise of a company's best sales associate, stylist or designer, elevating customer satisfaction and workforce efficiency. Using NVIDIA NeMo™ microservices provided within the blueprint, these highly skilled AI shopping assistants can under

    $NVDA
    Semiconductors
    Technology

$NVDA
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$NVDA
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$NVDA
SEC Filings

See more

$NVDA
Leadership Updates

Live Leadership Updates

See more
  • Olympian Motors and NVIDIA Pioneer the First AI-Powered EV Platforms

    BROOKLYN, N.Y., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Olympian Motors has announced an expanded collaboration with NVIDIA to advance the development of the Olympus Platform—a groundbreaking, open, modular and AI-powered electric vehicle (EV) platform. This strategic partnership leverages NVIDIA's advanced computing solutions, including the DRIVE AGX Orin™ platform, and the NVIDIA Inception Program, to create a new protocol to design, develop and deploy AI models and application to electric vehicles. The Olympus EV Platform introduces a novel modular approach to EV hardware and software architecture. The platform provides an easy and standardized access to vehicle data infrastructure, real-tim

    $NVDA
    Semiconductors
    Technology
  • NVIDIA and Sherwin-Williams Set to Join Dow Jones Industrial Average; Vistra to Join Dow Jones Utility Average

    NEW YORK, Nov. 1, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the Dow Jones Industrial Average (DJIA) and Dow Jones Utility Average (DJUA) effective prior to the open of trading on Friday, November 8: NVIDIA Corp. (NASD:NVDA) will replace Intel Corp. (NASD:INTC), and The Sherwin-Williams Co. (NYSE:SHW) will replace Dow Inc. (NYSE:DOW) in the Dow Jones Industrial Average. The index changes were initiated to ensure a more representative exposure to the semiconductors industry and the materials sector respectively. The DJIA is a price weighted index, and thus persistently lower priced stocks have a minimal impact on the index. Dow Inc. is also the smallest com

    $AES
    $DOW
    $INTC
    $NVDA
    Electric Utilities: Central
    Utilities
    Major Chemicals
    Industrials
  • NVIDIA Accelerates Humanoid Robotics Development

    Developers Gain Access to New NVIDIA NIM Microservices for Robotics Simulation in Isaac Lab and Isaac Sim, OSMO Robot Cloud Compute Orchestration Service, Teleoperated Data Capture Workflow and More DENVER, July 29, 2024 (GLOBE NEWSWIRE) -- SIGGRAPH—To accelerate humanoid development on a global scale, NVIDIA today announced it is providing the world's leading robot manufacturers, AI model developers and software makers with a suite of services, models and computing platforms to develop, train and build the next generation of humanoid robotics. Among the offerings are new NVIDIA NIM™ microservices and frameworks for robot simulation and learning, the NVIDIA OSMO orchestration service for

    $NVDA
    Semiconductors
    Technology

$NVDA
Financials

Live finance-specific insights

See more
  • NVDX Is The Best Performing ETF of 2024!

    The first 2x NVDA ETF in USA (Ticker: NVDX) led the ETF market with a 383% total return REX Financial ("REX"), a leader in innovative exchange-traded products, is proud to highlight that the T-Rex 2X Long NVIDIA Daily Target ETF (NVDX) was the best performing exchange-traded fund (ETF) of 2024, achieving a total return exceeding 383% in 2024, outperforming the second best performing ETF by over 38%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250115412925/en/(Graphic: Business Wire) Launched on October 19, 2023, NVDX was the first ever 2X daily target NVIDIA ETF available in the U.S. and has quickly gained traction among in

    $NVDA
    Semiconductors
    Technology
  • NVIDIA Announces Financial Results for Third Quarter Fiscal 2025

    Record quarterly revenue of $35.1 billion, up 17% from Q2 and up 94% from a year agoRecord quarterly Data Center revenue of $30.8 billion, up 17% from Q2 and up 112% from a year ago SANTA CLARA, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported revenue for the third quarter ended October 27, 2024, of $35.1 billion, up 17% from the previous quarter and up 94% from a year ago. For the quarter, GAAP earnings per diluted share was $0.78, up 16% from the previous quarter and up 111% from a year ago. Non-GAAP earnings per diluted share was $0.81, up 19% from the previous quarter and up 103% from a year ago. "The age of AI is in full steam, propelling a global

    $NVDA
    Semiconductors
    Technology
  • NVIDIA Sets Conference Call for Third-Quarter Financial Results

    SANTA CLARA, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- NVIDIA will host a conference call on Wednesday, November 20, at 2 p.m. PT (5 p.m. ET) to discuss its financial results for the third quarter of fiscal year 2025, which ended October 27, 2024. The call will be webcast live (in listen-only mode) on investor.nvidia.com. The company's prepared remarks will be followed by a question-and-answer session, which will be limited to questions from financial analysts and institutional investors. Ahead of the call, NVIDIA will provide written commentary on its third-quarter results from its chief financial officer, Colette Kress. This material will be posted to investor.nvidia.com im

    $NVDA
    Semiconductors
    Technology

$NVDA
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more